Tirzepatide is the active ingredient found in some well-known branded dual-agonist medications. What's offered through ILSA is a compounded tirzepatide — prepared by a licensed U.S.-based pharmacy when a provider authorizes treatment, and formulated here with supportive additives. It is not a branded product and is offered on a cash-pay basis. It belongs to the same dual GLP-1/GIP class; your provider can explain the specifics for your situation.

This is a compounded tirzepatide formulation that includes supportive additives alongside the active medication — most commonly B vitamins such as B6. They're included to help with the early adjustment period and to support energy while your body adapts, since the rough first few weeks are a frequent reason people stop. The additives complement, but do not replace, the careful dose titration your provider sets. Your provider and pharmacy can confirm the exact formulation prepared for you.

Both are once-weekly injectables that work with your gut hormones, but semaglutide targets a single receptor (GLP-1), while tirzepatide is a dual agonist that targets both GLP-1 and GIP. Engaging two complementary pathways is why tirzepatide is generally regarded as the more powerful option in the class, and in clinical studies it produced greater average weight loss. Which is right for you depends on your history, goals, and tolerability — a decision for your provider, not a one-size-fits-all answer.

Yes. Tirzepatide is a prescription medication. ILSA is a telehealth platform — it doesn't prescribe. Instead, ILSA connects you with independent, licensed providers who review your secure online intake and health history and determine whether tirzepatide is appropriate for you. If it isn't a good fit, they'll tell you. The clinical decision always rests with the provider.

Tirzepatide is a dual GIP and GLP-1 receptor agonist — it mimics two of the gut hormones released after eating. It slows how quickly your stomach empties (so you feel full longer) and acts on the brain's appetite centers (so you feel less hungry, with fewer cravings), while also supporting healthy blood-sugar regulation. Working two pathways at once is what gives the dual class its strength. Most people don't describe it as forcing themselves to eat less — they describe simply wanting less.

Results vary from person to person, and no honest provider can promise a number. In clinical studies, adults taking tirzepatide alongside diet and exercise lost a meaningful share of their body weight over time — but individual results depend on your starting point, dose, consistency, and lifestyle. It works best as part of healthy eating and movement, not instead of them. Your provider will help set realistic expectations for you.

Like any medication, tirzepatide can have side effects. The most common are gastrointestinal — nausea, and digestive changes — which often ease as your body adjusts and as the dose is increased gradually. Starting low and titrating up under provider guidance is designed to minimize them. More serious effects are less common. Your provider reviews your history, explains what to watch for, and is available if anything comes up. Always report concerning symptoms promptly.

Tirzepatide isn't right for everyone. It is generally not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, those who are pregnant or breastfeeding, and certain other conditions. This is exactly why a provider review is required: your individual history determines eligibility. Be complete and honest in your intake so the provider can make a safe decision.

Yes — tirzepatide is a small subcutaneous injection, typically once a week, using a fine needle. Your kit ships with the supplies you need, and the platform provides clear guidance on how to do it comfortably at home. Most people find it quick and far less daunting than they expected. If self-injecting concerns you, mention it in your intake so your provider can walk you through it.

Tirzepatide is available nationwide through the ILSA platform, subject to provider evaluation, eligibility, and the rules of your state. Whether treatment can be authorized depends on your individual review and where you live. The fastest way to find out is to start the online visit — there's no commitment until a provider approves.

Once a provider authorizes treatment, a licensed U.S.-based pharmacy prepares your tirzepatide and ships it cold-packed and discreetly to your door. It typically needs refrigeration, and your kit includes storage and handling instructions. If anything about a shipment looks off, reach out through the ILSA platform before using it.

The monthly price covers your provider-authorized tirzepatide with its supportive additives, injection supplies, your dosing plan, and ongoing support through the platform — all cash-pay, with no insurance required. Pricing is transparent with no hidden fees. Your provider determines your specific plan, and any details about ongoing fulfillment are made clear before you commit.

Yes. Your intake and health information are handled through HIPAA-compliant systems. Your data is used to connect you with a provider and fulfill an authorized order — not sold. You stay in control of your information throughout.